Green Thumb Industries (GTBIF) Capital Expenditures Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 28.56% |
| 10 | Green Thumb Industries | 1.64 Bn | 1.29 Bn | 143.65 Mn | -33.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.80% |
| Dec 31, 2025 | -37.33% |
| Sep 30, 2025 | -28.86% |
| Jun 30, 2025 | 9.94% |
| Mar 31, 2025 | -19.33% |
| Dec 31, 2024 | -27.27% |
| Sep 30, 2024 | -37.26% |
| Jun 30, 2024 | -6.45% |
| Mar 31, 2024 | -8.84% |
| Dec 31, 2023 | 51.04% |
| Sep 30, 2023 | 52.82% |
| Jun 30, 2023 | 45.77% |
| Mar 31, 2023 | 69.94% |
| Dec 31, 2022 | 40.11% |
| Sep 30, 2022 | 17.51% |
| Jun 30, 2022 | -16.48% |
| Mar 31, 2022 | 66.58% |